ALYSSA BRANSON: Open Payments
NPI 1245953470 · BELLEVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 22 payments from 11 companies in 2025. Trend: 2023 $1,891 · 2024 $1,722 · 2025 $476
Food & beverage: $476
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $107 |
| Novo Nordisk Inc | 3 | $59 |
| Lilly USA, LLC | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 3 | $55 |
| Astellas Pharma US Inc | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Lundbeck LLC | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: SPRAVATO, Ozempic, MOUNJARO, Veozah, ENTRESTO, BREZTRI, VYEPTI, REXULTI.
Industry payments across IL — which companies pay providers there.
